Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI035948-03
Application #
2071940
Study Section
Special Emphasis Panel (SRC (37))
Project Start
1994-09-01
Project End
1999-05-31
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Muhsen, Khitam; Lagos, Rosanna; Reymann, Mardi K et al. (2014) Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR. PLoS One 9:e83999
Lagos, Rosanna; Munoz, Alma; Valenzuela, Maria Teresa et al. (2002) Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile. Pediatr Infect Dis J 21:1115-23
Richie, E E; Punjabi, N H; Sidharta, Y Y et al. (2000) Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 18:2399-410
Lagos, R; Avendano, L F; Levine, M M (1999) [Systematic surveillance of influenza, syncytial respiratory, parainfluenza and adenovirus in children with acute respiratory infections] Rev Med Chil 127:1063-72
Levine, O S; Lagos, R; Munoz, A et al. (1999) Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J 18:1060-4
Levine, M M; Ferreccio, C; Abrego, P et al. (1999) Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17 Suppl 2:S22-7
Lagos, R; Fasano, A; Wasserman, S S et al. (1999) Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J Infect Dis 180:1709-12
Prado, V; Lagos, R; Nataro, J P et al. (1999) Population-based study of the incidence of Shigella diarrhea and causative serotypes in Santiago, Chile. Pediatr Infect Dis J 18:500-5
Lagos, R; San Martin, O; Wasserman, S S et al. (1999) Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers. Pediatr Infect Dis J 18:624-30
Lagos, R; Levine, O S; Avendano, A et al. (1998) The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries. Pediatr Infect Dis J 17:S139-48

Showing the most recent 10 out of 15 publications